The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function

MR Meyer, ER Prossnitz, M Barton - Vascular pharmacology, 2011 - Elsevier
Endogenous estrogens are important regulators of cardiovascular homeostasis in
premenopausal women and delay the development of hypertension and coronary artery …

The orphan receptor GPRC5B modulates inflammatory and fibrotic pathways in cardiac fibroblasts and mice hearts

FA von Samson-Himmelstjerna, G Freundt… - Biochemical and …, 2019 - Elsevier
Inflammation is a major driver of cardiac remodeling. Cardiac fibroblasts play an integral role
in cardiac inflammation, fibrosis and remodeling. The orphan G-protein-coupled-receptor 5B …

Regulatory role of G protein–coupled estrogen receptor for vascular function and obesity

E Haas, I Bhattacharya, E Brailoiu… - Circulation …, 2009 - Am Heart Assoc
We found that the selective stimulation of the intracellular, transmembrane G protein–
coupled estrogen receptor (GPER), also known as GPR30, acutely lowers blood pressure …

Regulation of beta adrenoceptor-mediated myocardial contraction and calcium dynamics by the G protein-coupled estrogen receptor 1

V Whitcomb, E Wauson, D Christian, S Clayton… - Biochemical …, 2020 - Elsevier
The G protein-coupled estrogen receptor 1 (GPER) produces cardioprotective effects.
However, the underlying mechanisms are not well understood. We aimed to investigate the …

Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen

M Satoh, CM Matter, H Ogita, K Takeshita, CY Wang… - Circulation, 2007 - Am Heart Assoc
Background—Epidemiological studies have shown gender differences in the incidence of
congestive heart failure (CHF); however, the role of estrogen in CHF is not known. We …

[HTML][HTML] 17β-Estradiol and/or estrogen receptor alpha signaling blocks protein phosphatase 1 mediated ISO induced cardiac hypertrophy

HY Fang, MY Hung, YM Lin, S Pandey, CC Chang… - PLoS …, 2018 - journals.plos.org
Earlier studies have shown that estrogen possess protective function against the
development of pathological cardiac hypertrophy. However, the molecular mechanisms of …

[HTML][HTML] Gypenoside protects against myocardial ischemia-reperfusion injury by inhibiting cardiomyocytes apoptosis via inhibition of CHOP pathway and activation of …

H Yu, H Zhang, W Zhao, L Guo, X Li, Y Li… - Cellular Physiology and …, 2016 - karger.com
Background/Aims: Ischemia-reperfusion (I/R) injury is believed to be the major cause for
detriments in coronary heart diseases, but few effective therapies for prevention or treatment …

Mechanism of cardioprotection: what can we learn from females?

E Murphy, C Lagranha, A Deschamps, M Kohr… - Pediatric …, 2011 - Springer
This review examines the mechanism of estrogen signaling in cardiomyocytes, with an
emphasis on mechanisms that might be important in cardioprotection. It investigates …

Vascular inflammation and atherosclerosis: the role of estrogen receptors

E Kassi, E Spilioti, N Nasiri-Ansari… - Current Medicinal …, 2015 - ingentaconnect.com
Estrogen receptors mediate numerous favorable effects on cells and molecules implicated in
vascular inflammation and atherogenic process. However, harmful effects have also been …

G protein-coupled estrogen receptor1 (GPER1) may mediate Rho-kinase (ROCK-2) up-regulation in coronary endothelial cells.

AH Kurt, RN Tiftik, I Un, S Ulker… - Endocrine Regulations, 2013 - europepmc.org
Objective Effect of estrogenic compounds and 17β-estradiol (E2), which induces endothelial
cell motility, was investigated on ROCK-2 expression in rat coronary vascular endothelial …